AN EARLY HISTORY OF GENE-TRANSFER AND THERAPY

被引:71
作者
WOLFF, JA
LEDERBERG, J
机构
[1] UNIV WISCONSIN, WAISMAN CTR, DEPT MED GENET, MADISON, WI 53705 USA
[2] UNIV WISCONSIN, WAISMAN CTR, DEPT NEUROL, MADISON, WI 53705 USA
[3] ROCKEFELLER UNIV, NEW YORK, NY 10021 USA
关键词
D O I
10.1089/hum.1994.5.4-469
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The term ''gene therapy'' was coined to distinguish it from the Orwellian connotations of ''human genetic engineering,'' which, in turn, was derived from the term ''genetic engineering.'' Genetic engineering was first used at the Sixth International Congress of Genetics held in 1932 and was taken to mean ''the application of genetic principles to animal and plant breeding.'' Once the basics of molecular genetics and gene transfer in bacteria were established in the 1960s, gene transfer into animals and humans using either viral vectors and/or genetically modified cultured cells became inevitable, Despite the early exposition of the concept of gene therapy, progress awaited the advent of recombinant DNA technology. The lack of trustworthy techniques did not stop many researchers from attempting to transfer genes into cells in culture, animals, and humans. Viral genomes were used for the development of the first relatively efficient methods for gene transfer into mammalian cells in culture. In the late 1970s, early transfection techniques were combined with selection systems for cultured cells and recombinant DNA technology. With the development of retroviral vectors in the early 1980s, the possibility of efficient gene transfer into mammalian cells for the purpose of gene therapy became widely accepted.
引用
收藏
页码:469 / 480
页数:12
相关论文
共 174 条
[101]  
MCCUTCHAN JH, 1968, JNCI-J NATL CANCER I, V41, P351
[102]   PART PLAYED BY DEOXYRIBONUCLEIC ACID IN TRANSPLANTATION IMMUNITY [J].
MEDAWAR, PB .
NATURE, 1958, 182 (4627) :62-62
[103]   AN INTESTINAL CARCINOMA IN MICE FOLLOWING INJECTION OF HERRING-SPERM DEOXYRIBONUCLEIC ACID [J].
MEEK, ES ;
HEWER, TF .
BRITISH JOURNAL OF CANCER, 1959, 13 (01) :121-&
[104]   INSERTION OF A NEW GENE OF VIRAL ORIGIN INTO BONE-MARROW CELLS OF MICE [J].
MERCOLA, KE ;
STANG, HD ;
BROWNE, J ;
SALSER, W ;
CLINE, MJ .
SCIENCE, 1980, 208 (4447) :1033-1035
[105]   GENERATION OF HELPER-FREE AMPHOTROPIC RETROVIRUSES THAT TRANSDUCE A DOMINANT-ACTING, METHOTREXATE-RESISTANT DIHYDROFOLATE-REDUCTASE GENE [J].
MILLER, AD ;
LAW, MF ;
VERMA, IM .
MOLECULAR AND CELLULAR BIOLOGY, 1985, 5 (03) :431-437
[106]  
MILLER AD, 1989, BIOTECHNIQUES, V7, P980
[107]   HUMAN GENE-THERAPY COMES OF AGE [J].
MILLER, AD .
NATURE, 1992, 357 (6378) :455-460
[108]   INTRODUCTION OF HERPES-SIMPLEX VIRUS THYMIDINE KINASE GENE INTO MOUSE CELLS USING VIRUS-DNA OR TRANSFORMED-CELL DNA [J].
MINSON, AC ;
WILDY, P ;
BUCHAN, A ;
DARBY, G .
CELL, 1978, 13 (03) :581-587
[109]   PROSPECTS FOR GENE THERAPY IN HUMANS [J].
MORROW, JF .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1976, 265 (JAN23) :13-21
[110]  
MOUNTAIN IM, 1959, P SOC EXP BIOL MED, V101, P527, DOI 10.3181/00379727-101-25005